Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Subject Area, Categories, Scope||Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1)|
|SCImago Journal Rank (SJR)||8.703|
|Publisher||BioMed Central Ltd.|
Molecular Cancer is an open access, peer-reviewed online journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.
Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer.
Molecular Cancer is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1). It is published by BioMed Central Ltd.. The overall rank of Molecular Cancer is 96. According to SCImago Journal Rank (SJR), this journal is ranked 8.703. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 171. The best quartile for this journal is Q1.
The ISSN of Molecular Cancer journal is 14764598. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Cancer is cited by a total of 17050 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Molecular Cancer is 28.85, which is computed in 2023 as per its definition. Molecular Cancer IF is decreased by a factor of 6.58 and approximate percentage change is -18.57% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Molecular Cancer is 28.85. If the same downward trend persists, Impact IF may fall in 2023 as well.
Molecular Cancer has an h-index of 171. It means 171 articles of this journal have more than 171 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Cancer is 14764598. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Cancer is 96. According to SCImago Journal Rank (SJR), this journal is ranked 8.703. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Molecular Cancer is published by BioMed Central Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2002-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Cancer is Mol. Cancer. This abbreviation ('Mol. Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q1); Molecular Medicine (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Cancer latest impact IF is 28.85. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 35.43 (2021) and 4.80 (2014), respectively, in the last 9 years. Moreover, its average IS is 15.64 in the previous 9 years.
The Molecular Cancer has an SJR (SCImago Journal Rank) of 8.703, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 8.703 in 2022 and the lowest being 2.406 in 2015. Furthermore, the average SJR of the Molecular Cancer over the previous 9-year period stands at 15.64.
The latest h-index of the Molecular Cancer is 171.
The Molecular Cancer is published by the BioMed Central Ltd., with its country of publication being the United Kingdom.
The Molecular Cancer is currently ranked 96 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 96 in 2022 and its lowest position of 1014 in 2015.
The standard ISO4 abbreviation for the Molecular Cancer is Mol. Cancer.
Molecular Cancer is classified as a journal that the BioMed Central Ltd. publishes.
The Molecular Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Cancer is assigned the following International Standard Serial Numbers (ISSN): 14764598.
The best quartile for the Molecular Cancer is Q1 (2022).
The Molecular Cancer coverage history can be summarized as follows: 2002-2022.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Journal of Field Archaeology||journal||5639||Maney Publishing||43||2.38|
|Proceedings of the ASME Turbo Expo||conference and proceedings||17577||54||0.00|
|Journal of International Financial Management and Accounting||journal||6179||Wiley-Blackwell Publishing Ltd||42||6.09|
|Canadian Journal of Education||journal||17961||Canadian Society for the Study of Education (CSSE)||41||0.39|
|British Journal of Special Education||journal||12024||Wiley-Blackwell Publishing Ltd||42||1.24|
|Transnational Corporations||journal||6120||UNCTAD United Nations Conference on Trade and Development||27||1.92|
|Educational Measurement: Issues and Practice||journal||4494||Wiley-Blackwell Publishing Ltd||59||1.53|
|Proceedings of the International Semiconductor Conference, CAS||conference and proceedings||25734||Institute of Electrical and Electronics Engineers Inc.||16||0.00|
|Oral Radiology||journal||9461||Springer Japan||20||2.06|
|Consulting engineer Barrington||journal||24079||Cahners Pub. Co.||0||0.00|
|Year||Impact Score (IS)|